The Children's Investment Fund Foundation Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2017
NCT03079388
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Children's Investment Fund Foundation | The Children's Investment Fund Foundation